These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 35186127)

  • 1. The role of antifibrotics in the treatment of rheumatoid arthritis-associated interstitial lung disease.
    Liang M; Matteson EL; Abril A; Distler JHW
    Ther Adv Musculoskelet Dis; 2022; 14():1759720X221074457. PubMed ID: 35186127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and tolerability of antifibrotics in rheumatoid arthritis-associated interstitial lung disease.
    Juge PA; Hayashi K; McDermott GC; Vanni KMM; Kowalski E; Qian G; Bade K; Saavedra A; Dieudé P; Dellaripa PF; Doyle TJ; Sparks JA
    Semin Arthritis Rheum; 2024 Feb; 64():152312. PubMed ID: 38056314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of antifibrotic agents in the treatment of CTD-ILD and RA-ILD: A systematic review and meta-analysis.
    Yang M; Wu Y; Liu X; Zhao C; Li T; Li T; Zhang X; Jiang H; Mao B; Liu W
    Respir Med; 2023 Sep; 216():107329. PubMed ID: 37315742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifibrotics in rheumatoid arthritis-associated interstitial lung disease - real-world data from a nationwide cohort.
    Duarte AC; Marques Gomes C; Correia M; Mendes B; Mazeda C; Guimarães F; Abelha-Aleixo J; Guerra M; Pereira da Costa R; Meirinhos T; Santos MJ
    ARP Rheumatol; 2024; 3(3):182-188. PubMed ID: 39368099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of nintedanib in patients with progressive pulmonary fibrosis associated with rheumatoid arthritis: data from the INBUILD trial.
    Matteson EL; Aringer M; Burmester GR; Mueller H; Moros L; Kolb M
    Clin Rheumatol; 2023 Sep; 42(9):2311-2319. PubMed ID: 37209188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Design and Rationale of the Trail1 Trial: A Randomized Double-Blind Phase 2 Clinical Trial of Pirfenidone in Rheumatoid Arthritis-Associated Interstitial Lung Disease.
    Solomon JJ; Danoff SK; Goldberg HJ; Woodhead F; Kolb M; Chambers DC; DiFranco D; Spino C; Haynes-Harp S; Hurwitz S; Peters EB; Dellaripa PF; Rosas IO;
    Adv Ther; 2019 Nov; 36(11):3279-3287. PubMed ID: 31515704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antifibrotic Agents in Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Systematic Review and Meta-Analysis.
    Jang JH; Ko J; Jung SY; Kim DW; Oh JH; Kim TJ; Park JH; Choi M; Lee JH
    Life (Basel); 2023 Dec; 13(12):. PubMed ID: 38137919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifibrotics in the Management of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Prospective Real-World Experience From an Interstitial Lung Disease Clinic in India.
    Behera AK; Kumar V; Sharma P; Ganga R; Meher J; Pati S; Sinha K
    Cureus; 2024 Jun; 16(6):e63518. PubMed ID: 39081417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study.
    Solomon JJ; Danoff SK; Woodhead FA; Hurwitz S; Maurer R; Glaspole I; Dellaripa PF; Gooptu B; Vassallo R; Cox PG; Flaherty KR; Adamali HI; Gibbons MA; Troy L; Forrest IA; Lasky JA; Spencer LG; Golden J; Scholand MB; Chaudhuri N; Perrella MA; Lynch DA; Chambers DC; Kolb M; Spino C; Raghu G; Goldberg HJ; Rosas IO;
    Lancet Respir Med; 2023 Jan; 11(1):87-96. PubMed ID: 36075242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of Rheumatoid Arthritis-Associated Interstitial Lung Disease and Its Treatment.
    Pugashetti JV; Lee JS
    Semin Respir Crit Care Med; 2024 Jun; 45(3):329-341. PubMed ID: 38484788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifibrotic Therapies and Progressive Fibrosing Interstitial Lung Disease (PF-ILD): Building on INBUILD.
    Shumar JN; Chandel A; King CS
    J Clin Med; 2021 May; 10(11):. PubMed ID: 34070297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in rheumatoid arthritis-associated interstitial lung disease.
    Juge PA; Crestani B; Dieudé P
    Curr Opin Pulm Med; 2020 Sep; 26(5):477-486. PubMed ID: 32701675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary fibrosis associated with rheumatoid arthritis: from pathophysiology to treatment strategies.
    Diesler R; Cottin V
    Expert Rev Respir Med; 2022 May; 16(5):541-553. PubMed ID: 35695895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial.
    Wells AU; Flaherty KR; Brown KK; Inoue Y; Devaraj A; Richeldi L; Moua T; Crestani B; Wuyts WA; Stowasser S; Quaresma M; Goeldner RG; Schlenker-Herceg R; Kolb M;
    Lancet Respir Med; 2020 May; 8(5):453-460. PubMed ID: 32145830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrosing Progressive Interstitial Lung Disease in Rheumatoid Arthritis: A Multicentre Italian Study.
    Sebastiani M; Venerito V; Laurino E; Gentileschi S; Atzeni F; Canofari C; Andrisani D; Cassone G; Lavista M; D'Alessandro F; Vacchi C; Scardapane A; Frediani B; Cazzato M; Salvarani C; Iannone F; Manfredi A
    J Clin Med; 2023 Nov; 12(22):. PubMed ID: 38002655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential Rheumatoid Arthritis-Associated Interstitial Lung Disease Treatment and Computational Approach for Future Drug Development.
    Jeong E; Hong H; Lee YA; Kim KS
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis, clinical features, and treatment strategy for rheumatoid arthritis-associated interstitial lung disease.
    Akiyama M; Kaneko Y
    Autoimmun Rev; 2022 May; 21(5):103056. PubMed ID: 35121155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive fibrosing interstitial lung diseases: A new concept and indication of nintedanib.
    Makino S
    Mod Rheumatol; 2021 Jan; 31(1):13-19. PubMed ID: 32964766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of antifibrotics in the management of idiopathic inflammatory myopathy associated interstitial lung disease.
    Wilfong EM; Aggarwal R
    Ther Adv Musculoskelet Dis; 2021; 13():1759720X211060907. PubMed ID: 34917177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-World Study Analysing Progression and Survival of Patients with Idiopathic Pulmonary Fibrosis with Preserved Lung Function on Antifibrotic Treatment.
    Noor S; Nawaz S; Chaudhuri N
    Adv Ther; 2021 Jan; 38(1):268-277. PubMed ID: 33098554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.